Chester County News and Community Website
WILMINGTON, DE — The Apache Software Foundation (ASF) has released Apache Grails 7.0.0, marking the project’s first major update since graduating to a top-level ASF project. The release brings a …
Apache Grails 7.0.0 Debuts With Major Overhaul and Modernized Framework Read More
WILMINGTON, DE — Aimfinity Investment Corp. I (OTC: AIMTF) announced that shareholders approved several key amendments during an extraordinary general meeting held last week, granting the company additional time to …
Aimfinity Shareholders Approve Extension to Complete Business Merger Read More WILMINGTON, DE — Onfolio Holdings Inc. (Nasdaq: ONFO, ONFOW) (OTC: ONFOP), an acquirer and operator of online businesses, announced the successful completion of a $1 million private offering to accredited …
Onfolio Raises $1 Million to Fuel Expansion of Its Online Business Portfolio Read More
WILMINGTON, DE — WSFS Financial Corporation (Nasdaq: WSFS), the parent company of WSFS Bank, reported earnings per share (EPS) of $1.37 for the third quarter of 2025, marking a 27% …
WSFS Financial Reports Strong Q3 Results with 27% EPS Growth and Higher Margins Read More WILMINGTON, DE — EnterpriseDB (EDB) has launched AI & Data Horizons: The Sovereign Future, a new podcast series exploring how artificial intelligence and data sovereignty are redefining business, technology, and …
EnterpriseDB Launches “AI & Data Horizons” Podcast on the Future of Intelligence Read More
WILMINGTON, DE — Global Indemnity Group, LLC (NASDAQ: GBLI) announced that it has officially transferred the listing of its Class A common shares from the New York Stock Exchange to …
Global Indemnity Moves to Nasdaq, Unveils Bold Restructuring and Tech-Focused Strategy Read More
WILMINGTON, DE — In a major advance for breast cancer treatment, AstraZeneca and Daiichi Sankyo announced that their drug DATROWAY (datopotamab deruxtecan-dlnk) extended the lives of patients with metastatic triple-negative …
Breakthrough Drug Shows Unprecedented Survival Gains in Aggressive Breast Cancer Read More WILMINGTON, DE — AstraZeneca and Daiichi Sankyo reported breakthrough results from the Phase III DESTINY-Breast05 trial, showing that their drug ENHERTU (fam-trastuzumab deruxtecan-nxki) cut the risk of disease recurrence or …
AstraZeneca’s Enhertu Slashes Breast Cancer Recurrence Risk in Landmark Trial Read More
WILMINGTON, DE — Amalgam Rx, Inc. announced the publication of two peer-reviewed research papers validating its Medical-Grade AI™ framework, a clinically governed system that delivers safe and highly engaging digital …
Amalgam Rx’s Medical-Grade AI Redefines Safety and Engagement in Healthcare Read More
WILMINGTON, DE — InterDigital, Inc. (Nasdaq: IDCC) announced it has renewed a multi-year, worldwide, non-exclusive, royalty-bearing patent license agreement with Seiko Solutions Inc., extending its long-standing relationship with the Japanese …
InterDigital Renews Global Patent License with Seiko Solutions Covering 3G, 4G, and 5G Technologies Read More